- Company invited to
speak during three symposia on the impact of quality improvement,
the cost of disparities in diabetes care, and addressing racial
inequities – showcasing leadership in real-world diabetes data,
equity, and practical
implementation.
-
Company announces the new diabetes equity-focused ADEPT
Conference, "Achieving Diabetes Equity in Practice Today," in
collaboration with American Diabetes Association.
BOSTON, June 17,
2024 /PRNewswire/ -- T1D Exchange, a nonprofit
organization that drives meaningful research and improvement in
care and outcomes in type 1 and type 2 diabetes, today announced
that new research using real-world data from its Quality
Improvement Collaborative (T1DX-QI) and online patient Registry
will be shared in nine oral and 12 poster presentations during the
84th Scientific Sessions being held June
21-24, 2024, in Orlando,
Florida.
The studies detail trends and outcomes in the management of
diabetes, including the importance of collaboration to close gaps
and improve outcomes, the off-label use of glucagon-like peptide-1
(GLP-1) in people with type 1 diabetes (T1D), and varying
characteristics and symptoms among users of continuous glucose
monitors (CGMs). For a second consecutive year, T1D Exchange was
selected for an ADA Presidents' Select Abstract, and this year the
oral presentation is titled "Dynamics of Treatment Regimens and
Glycemic Outcomes in >100,000 Children from International
Pediatrics Diabetes Registries." A full list of abstracts can be
found here.
"We're thrilled to share compelling research utilizing data from
our core programs, the Quality Improvement Collaborative and
patient Registry, both of which continue to grow," said
David Walton, Chief Executive
Officer of T1D Exchange. "Our expanded research capabilities
and comprehensive patient data can generate novel insights to help
partners improve products and care delivery."
Oral Presentations & Symposia
- ADA Scholars Session: Does Quality Improvement Impact Outcomes
for People Living with Diabetes?
- Examining New-Onset Type 1 Diabetes Educational Practices among
Centers in the T1D Exchange Quality Improvement Collaborative
(T1DX-QI)
- Longitudinal Assessment of Glycemia and Severe Hypoglycemia
Among Adults with T1D: An Online Survey
- Health-related Quality of Life and Burden of Type 1 Diabetes
and Severe Hypoglycemia in Adult Continuous Glucose Monitor
Users
- Association of Type 1 Diabetes Duration or Duration of Advanced
Technology Utilization with Severe Hypoglycemic Event
Frequency
- Understanding Patterns of GLP-1/GLP-1 RA Use Among Individuals
with Type 1 Diabetes: A T1D Exchange (T1DX) Online Registry
Analysis
- ADA Presidents' Select Abstract: Dynamics of Treatment Regimens
and Glycemic Outcomes in >100,000 Children from International
Pediatrics Diabetes Registries
- Improving Diabetes Outcomes and Reducing Inequities through
Collaboration: Perspective from the T1D Exchange
- Current Approaches to Addressing Racial Equity—Insights from
the T1D Exchange QI Collaborative
Additionally, data from 12 studies will be presented during the
General Poster Sessions on Saturday, June
22, and Sunday, June 23, at
12:30 - 1:30 p.m. ET in the Poster
Hall West Hall A4-B2.
"The T1DX-QI network of over 60 diabetes centers cares for over
160,000 people living with type 1 and type 2 diabetes across the
country," said Osagie Ebekozien, MD, MPH, Executive Vice
President, Chief Medical Officer at T1D Exchange. "Our data and
collaborative work highlight the importance of ongoing partnerships
with diabetes centers to improve outcomes, advance new treatments,
and close equity gaps."
"With a direct connection to more than 20,000 people living with
T1D, we've continued to expand our cohort and dataset to capture
the daily experiences and challenges of individuals living with
diabetes," said Wendy Wolf,
PhD, Vice President of Registry and Outcomes Research at T1D
Exchange. "Our research capabilities continue to expand as
well, and we're now harnessing the power of patient-reported
outcomes data linked with real-world CGM data of 3,500 individuals
– enabling us to provide organizations with key data and insights
to improve therapies for people living with T1D."
ADEPT Health Equity Conference
The T1DX-QI has identified practical, evidence-based solutions
to address diabetes health equity. To further their commitment, T1D
Exchange has partnered with the American Diabetes Association to
host a conference to address health equity in diabetes.
The first annual ADEPT Health Equity Conference, "Achieving
Diabetes Equity in Practice Today," will convene stakeholders who
share a common interest in improving health equity in all types of
diabetes. Taking place in Chicago
on November 12-13, 2024, attendees
will join together to contribute solutions, learn from others, and
build meaningful connections with a network of health equity
champions.
Registration is now open at adeptconference.org.
About the T1DX-QI and the T1D Exchange Registry
The
T1D Exchange Quality Improvement Collaborative (T1DX-QI) brings
together 60+ endocrinology centers across the U.S., collectively
treating more than 160,000 people living with type 1 and type 2
diabetes, to identify and address gaps in care and accelerate
evidence-based, practical solutions. Participating centers
contribute anonymized patient data and research from their
respective clinics, expanding the collective knowledge base and
creating a unified data asset to expedite improvements in care for
all people living with type 1 and type 2 diabetes.
The T1D Exchange Registry is a longitudinal study that tracks
disease progress over time and gathers information directly from
people with type 1 diabetes and caregivers. To date, the Registry
includes over 20,000 participants in the U.S. These individuals
share patient-reported outcomes, including data on disease
management. Participants update their information annually,
participate in internal research projects, and are connected to
external curated research opportunities, including clinical trials.
The online Registry is designed to lower the barrier to
participating in diabetes research, including patient populations
often underrepresented in clinical studies.
About T1D Exchange
T1D Exchange is a leader in
harnessing data to advance diabetes care and outcomes by
driving collaborative change. Through real-world evidence
and clinical data collection and analysis, our novel
insights are identifying gaps in data and
refining best practices to improve the lives of those
living with diabetes. T1D Exchange actively supports quality
improvement and innovation through its Quality Improvement
Collaborative (T1DX-QI), patient registry, and data-oriented
research services. Through a knowledge-sharing and
collaboration-focused approach, T1D Exchange is accelerating
real-world impact by providing clinicians,
researchers, industry partners, and advocates with the resources
and services they need for better decision support and population
health management. A nonprofit organization, T1D Exchange
was established in 2010 with ongoing support from The
Leona M. and Harry B. Helmsley Charitable Trust.
To learn more about T1DX-QI member clinics, click here. For
more information on the Registry, visit t1dregistry.org.
Media Contact:
Deborah Taylor
Senior Director of Marketing and Business Development, T1D
Exchange
Phone: 651-500-4252
Email: dtaylor@t1dexchange.org
View original content to download
multimedia:https://www.prnewswire.com/news-releases/t1d-exchange-announces-21-real-world-data-presentations-at-the-american-diabetes-association-ada-84th-scientific-sessions-302174326.html
SOURCE T1D Exchange